Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Infectious Disease Information
1007-8134
2015 Issue 5
Advances in novel anti-HBV agents acting on different targets
XU Zhi-hui;LIU Yan;XU Dong-ping;Research Center for Clinical Medicine;302 Hospital of PLA;
..............page:257-261+283
Combination therapy with interferons and nucleos(t)ide analogues creating a new way of HBsAg clearance
CHEN Xin-yue;LIU Ya-li;International Medical Department;Beijing You’an Hospital;Capital Medical University;
..............page:262-265
Clinical practice of direct-acting antiviral agents for chronic HCV infection
RAO Hui-ying;Peking University People’s Hospital;Peking University Hepatology Institute;Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases;
..............page:266-269
Current status and prospect of diagnosis and treatment of inherited metabolic liver disease in children
ZHU Shi-shu;ZHANG Hong-fei;Pediatric Liver Diseases Treatment and Research Center;302 Hospital of PLA;
..............page:270-272+292
Combination therapy in HBeAg-positive chronic hepatitis B patients with poor virological response/HBV resistance to NAs
JIN Yi;HUANG Chun-yang;WEI Fei-li;HE Zhi-min;ZHENG Yan-hong;MA Li-na;CHEN Xin-yue;International Medical Department;You’an Hospital;Capital Medical University;
..............page:273-278
Efficacy and safety of interferon combined with lamivudine in treatment of cirrhotic children with HBe Ag-positive compensated hepatitis B
DONG Yi;ZHANG Hong-fei;XU Zhi-qiang;CHEN Da-wei;GAN Yu;WANG Li-min;WANG Fu-chuan;YAN Jian-guo;ZHANG Min;ZHU Shi-shu;Pediatric Liver Diseases Treatment and Research Center;302 Hospital of PLA;
..............page:279-283
Preliminary clinical observation of direct-acting antiviral agents in patients with HCV-related liver cirrhosis and HCV recurrence after liver transplantation
ZHANG Min;SU Hai-bin;ZHOU Shuang-nan;ZHOU Xia;HE Xi;ZHANG Da-li;TANG Ru-jia;LIU Zhen-wen;Liver Transplantation Center;302 Hospital of PLA;
..............page:284-287
Risk factors for infections in patients with acute-on-chronic liver failure and their influences on short-term outcome
ZANG Hong;LIU Hong-ling;HAO Yu-qing;WEN Bin;ZHU Bing;LIU Wan-shu;XIN Shao-jie;YOU Shao-li;Liver Failure Treatment and Research Center;302 Hospital of PLA;
..............page:288-292
Clinical study of transjugular intrahepatic porto-systemic shunt combined with esophageal varices embolization
KUAI Tao;LIU Fu-quan;YUE Zhen-dong;ZHAO Hong-wei;WANG Lei;FANG Zhen-hua;ZHAO Meng-fei;HE Fu-liang;YU Hai-yang;Department of Interventional Therapy;Beijing Shijitan Hospital;Capital Medical University;
..............page:293-296
Application of early restrictive fluid resuscitation combined with painless gastroscope in the treatment of massive upper gastrointestinal bleeding in liver cirrhotic patients
WANG Xiao-mei;ZHAO Rui;WU Yun-hai;ZHANG Ming-xiang;ZHANG Li-yao;SUN Li;MU Feng;Department of Liver Diseases;Sixth People’s Hospital of Shenyang;
..............page:297-300
Efficacy and prognostic factors of cyberknife treatment combined with transcatheter arterial chemoembolization therapy for primary liver cancer
XUE Hui;ZHONG Qing;LIU Hu;HAN Ping;ZHANG Ai-min;LI Wen-gang;LIANG Yan;LIANG Xue-feng;CHANG Xiao-yun;DUAN Xue-zhang;Center for Radiation Oncology;302 Hospital of PLA;
..............page:301-305
Research progress of the relationship between HBV mutations and occurrence of hepatocellular carcinoma
NIAN Xue-yuan;XU Zhi-hui;LIU Yan;XU Dong-ping;Research Center for Clinical Medicine;302 Hospital of PLA;
..............page:306-309
Unneglected hepatitis E
XIAO Long;XIN Shao-jie;MAO Pan-yong;Postgraduate Squad;PLA Medical Collage;
..............page:310-312
Discussion of diagnosis, prognosis and treatment of alcoholic hepatitis
ZOU Zheng-sheng;CHANG Bin-xia;Diagnosis;Treatment and Research Center for Non-infectious Liver Diseases;302 Hospital of PLA;
..............page:312-316
Recent advances in diagnosis and treatment of non-alcoholic fatty liver disease
ZHANG Jing;HU Zhong-jie;Department of Fatty Liver Disease;Beijing You’an Hospital;Capital Medical University;
..............page:316-320